Evidence map›Paper›PMID 24677136›Full record

ArticleJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research2014

Role of Fas and Treg cells in fracture healing as characterized in the fas-deficient (lpr) mouse model of lupus.

Maisa O Al-Sebaei, Dana M Daukss, Anna C Belkina, Sanjeev Kakar, Nathan A Wigner, Daniel Cusher, Dana Graves, Thomas Einhorn, Elise Morgan, Louis C Gerstenfeld

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Osteoimmunology of Fracture Healing.Current osteoporosis reports · 2024
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Role of the Immune Cells in Fracture Healing.Current osteoporosis reports · 2018
    Review
  11. Effects of Aging on Fracture Healing.Current osteoporosis reports · 2017
    Review
  12. Osteoimmunology in Bone Fracture Healing.Current osteoporosis reports · 2017
    Review
  13. Article
  14. Fracture healing: mechanisms and interventions.Nature reviews. Rheumatology · 2015
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Maisa O Al-SebaeiOrthopaedic Research Laboratory, Boston University School of Medicine, Boston, MA, USA; King Abdul Aziz University, Faculty of Dentistry, Department of Oral and Maxillofacial Surgery, Jeddah, Saudi Arabia.
Dana M Daukss
Anna C Belkina
Sanjeev Kakar
Nathan A Wigner
Daniel Cusher
Dana Graves
Thomas Einhorn
Elise Morgan
Louis C Gerstenfeld
Boston University · USOrthopaedic Research · GBKing Abdul Aziz University Hospital · SAUniversity of Pennsylvania · US

Funding

Role of VEGF in Fracture RepairP01AR049920 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BARNES, GEORGE L · 2004 to 2008
$5.4M
FUNCTIONAL ROLE OF TNF-ALPHA CYTOKINES IN BONE REPAIRR01AR047045 · NIAMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GERSTENFELD, LOUIS CHARLES · 2001 to 2004
$1.2M
NIAMS NIH HHS AR 47045NIAMS NIH HHS P01 AR049920NIAMS NIH HHS R01 AR047045
6 · The paper itself

Abstract

Previous studies showed that loss of tumor necrosis factor α (TNFα) signaling delayed fracture healing by delaying chondrocyte apoptosis and cartilage resorption. Mechanistic studies showed that TNFα induced Fas expression within chondrocytes; however, the degree to which chondrocyte apoptosis is mediated by TNFα alone or dependent on the induction of Fas is unclear. This question was addressed by assessing fracture healing in Fas-deficient B6.MRL/Fas(lpr) /J mice. Loss of Fas delayed cartilage resorption but also lowered bone fraction in the calluses. The reduced bone fraction was related to elevated rates of coupled bone turnover in the B6.MRL/Fas(lpr) /J calluses, as evidenced by higher osteoclast numbers and increased osteogenesis. Analysis of the apoptotic marker caspase 3 showed fewer positive chondrocytes and osteoclasts in calluses of B6.MRL/Fas(lpr) /J mice. To determine if an active autoimmune state contributed to increased bone turnover, the levels of activated T cells and Treg cells were assessed. B6.MRL/Fas(lpr) /J mice had elevated Treg cells in both spleens and bones of B6.MRL/Fas(lpr) /J but decreased percentage of activated T cells in bone tissues. Fracture led to ∼30% to 60% systemic increase in Treg cells in both wild-type and B6.MRL/Fas(lpr) /J bone tissues during the period of cartilage formation and resorption but either decreased (wild type) or left unchanged (B6.MRL/Fas(lpr) /J) the numbers of activated T cells in bone. These results show that an active autoimmune state is inhibited during the period of cartilage resorption and suggest that iTreg cells play a functional role in this process. These data show that loss of Fas activity specifically in chondrocytes prolonged the life span of chondrocytes and that Fas synergized with TNFα signaling to mediate chondrocyte apoptosis. Conversely, loss of Fas systemically led to increased osteoclast numbers during later periods of fracture healing and increased osteogenesis. These findings suggest that retention of viable chondrocytes locally inhibits osteoclast activity or matrix proteolysis during cartilage resorption.

Indexed as

Fracture HealingAnimalsApoptosisBiomechanical PhenomenaBone and BonesBone RemodelingBony CallusCartilageDisease Models, Animalfas ReceptorFractures, BoneInflammationLupus Erythematosus, SystemicMice, Inbred C57BLMice, Inbred MRL lprOrgan SpecificityFas protein, mousefas ReceptorRNA, MessengerAPOPTOSISCHONDROCYTESFASOSTEOCLASTSTREG CELLS

Identifiers

PMID24677136
PMCPMC4305200
OpenAlexW1494840390

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.